LON:PXS Provexis (PXS) Share Price, News & Analysis GBX 0.62 0.00 (0.00%) As of 10/1/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsBuy This Stock About Provexis Stock (LON:PXS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Provexis alerts:Sign Up Key Stats Today's Range 0.56▼ 0.6350-Day Range 0.61▼ 0.7852-Week Range 0.06▼ 0.95VolumeN/AAverage Volume1.06 million shsMarket Capitalization£14.49 millionP/E RatioN/ADividend Yield5.06%Price TargetN/AConsensus RatingN/A Company Overview Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom. Read More Receive PXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Provexis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PXS Stock News HeadlinesProvexis Faces Temporary Trading Suspension Amid Financial Reporting DelaySeptember 30, 2025 | tipranks.comPhase I trial finds topical PXS-6302 generally well tolerated in established skin scarsSeptember 12, 2025 | msn.comAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.October 18 at 2:00 AM | Porter & Company (Ad)Provexis (LON:PXS) Is In A Strong Position To Grow Its BusinessJune 28, 2025 | finance.yahoo.comParagon Care Limited (PXS) Receives a Buy from Ord MinnettFebruary 28, 2025 | markets.businessinsider.comProvexis Grants Options and Warrants to CEO and ConsultantsJanuary 7, 2025 | tipranks.comProvexis Share Chat (PXS)September 17, 2024 | lse.co.ukPXS Stock Earnings: Pyxis Tankers Reported Results for Q1 2024May 21, 2024 | msn.comSee More Headlines PXS Stock Analysis - Frequently Asked Questions How have PXS shares performed this year? Provexis' stock was trading at GBX 0.65 at the beginning of the year. Since then, PXS shares have decreased by 5.0% and is now trading at GBX 0.62. How were Provexis' earnings last quarter? Provexis plc (LON:PXS) issued its earnings results on Wednesday, September, 30th. The company reported ($0.02) EPS for the quarter. Provexis had a negative net margin of 73.10% and a negative trailing twelve-month return on equity of 68.68%. How do I buy shares of Provexis? Shares of PXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Provexis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Provexis investors own include Reckitt Benckiser Group (RB), Taylor Wimpey (TW), Bionano Genomics (BNGO), Bristol Myers Squibb (BMY), Bumble (BMBL), BEST (BEST) and Alibaba Group (BABA). Company Calendar Last Earnings9/30/2020Today10/18/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryTransportation Current SymbolLON:PXS CIKN/A Webwww.provexis.org Phone+44-1753-861777FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£619.15 thousand Net Margins-73.10% Pretax MarginN/A Return on Equity-68.68% Return on Assets-56.14% Debt Debt-to-Equity RatioN/A Current Ratio1.62 Quick Ratio6.21 Sales & Book Value Annual Sales£1.20 million Price / Sales12.07 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 0.01 per share Price / Book71.99Miscellaneous Outstanding Shares2,345,891,000Free FloatN/AMarket Cap£14.49 million OptionableNot Optionable Beta1.21 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (LON:PXS) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredThe “smart money” is piling into one AI power company.Expert Reveals: The #1 Energy Play for 2025 "We're Entering the Greatest Energy Bull Market Since the Indus...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
